A61K 38/02
Peptides of undefined number of amino acids
Official title: Peptides of undefined number of amino acids; Derivatives thereof
A61K38/02 (Peptides of undefined number of amino acids) appears on 584 US grants and 1,018 published applications in this corpus.
Search patents in A61K- Granted patents
- 584
- Published applications
- 1,018
- Assignees
- 503
- Inventors
- 1,635
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 4 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 2 |
| 2002 | 2 | 8 |
| 2003 | 3 | 13 |
| 2004 | 5 | 11 |
| 2005 | 4 | 27 |
| 2006 | 6 | 29 |
| 2007 | 5 | 21 |
| 2008 | 6 | 25 |
| 2009 | 15 | 38 |
| 2010 | 12 | 46 |
| 2011 | 19 | 52 |
| 2012 | 24 | 52 |
| 2013 | 37 | 75 |
| 2014 | 38 | 75 |
| 2015 | 53 | 74 |
| 2016 | 47 | 59 |
| 2017 | 39 | 78 |
| 2018 | 38 | 78 |
| 2019 | 55 | 58 |
| 2020 | 36 | 43 |
| 2021 | 46 | 36 |
| 2022 | 21 | 22 |
| 2023 | 20 | 21 |
| 2024 | 20 | 32 |
| 2025 | 16 | 29 |
| 2026 | 6 | 14 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Modified antibodies15 Sep 2026US 12,734,208 B2Janux Therapeutics, Inc.
- Parathyroid hormone receptor 1(PTH1R) antibodies and uses thereof4 Aug 2026US 12,698,346 B2Xoma (US) LLC
- Nanoparticle drug targeting JFK and use thereof21 Apr 2026US 12,605,337 B2Peking University
- Engineered nucleases that target human and canine factor VIII genes as a treatment for hemophilia A7 Apr 2026US 12,595,470 B2Precision BioSciences, Inc.
- Messenger RNA therapy for the treatment of Friedreich's ataxia10 Mar 2026US 12,569,572 B2Translate Bio, Inc.
- Reducing systemic regulatory t cell levels or activity for treatment of disease and injury of the cns1 Oct 2026US 2026/0297191 A1ImmunoBrain Checkpoint, Inc.
- Topical composition and uses thereof10 Sep 2026US 2026/0263401 A1Toxfinder, Lda.
- Peptide-based vaccines, methods of manufacturing, and uses thereof for inducing an immune response27 Aug 2026US 2026/0248912 A1Barinthus Biotherapeutics North America, Inc.
- Engineered nucleases that target human and canine factor viii genes as a treatment for hemophilia a23 Jul 2026US 2026/0209731 A1Precision BioSciences, Inc.
- Devices and methods for extracorporeal cell treatment18 Jun 2026US 2026/0166171 A1Lupagen, Inc.
Most cited
By later US patents
- Lipids and compositions for intracellular delivery of biologically active compounds247US 8,691,750 B2Axolabs GmbH · 2014
- Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth243US 6,861,053 B1Cedars-Sinai Medical Center · 2005
- Aminoalcohol lipidoids and uses thereof207US 8,450,298 B2Massachusetts Institute of Technology · 2013
- Aminoalcohol lipidoids and uses thereof109US 8,969,353 B2Massachusetts Institute of Technology · 2015
- Stable topical drug delivery compositions100US 7,182,956 B22007